Stock Taper
SCREENER COMPARE ANY 2 STOCKS
TELO
TELOMIR PHARMACEUTICALS, INC. COMMON STOCK
NASDAQ
$1.14
▼ DOWN 4.20% (-0.05)

KEY STATISTICS

Market Cap$78.40 M
52w High$2.09
52w Low$0.89
Dividend Yield—
Frequency—
P/E-3.93
Volume36.96K
Shares Out.68.77M

COMPANY

LEADERSHIP

Erez Aminov
CHIEF EXECUTIVE
Erez Aminov

COMPENSATION 2026

Salary$275,000
Stock Awards$840,000
Incentive Plan Pay$0
All Other Comp.$21,350
Total$4,880,350

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 9, 2024
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
2

UPCOMING EARNINGS

DateDec 2, 2026
DayWednesday
Rev. Est.$500.00K
DEC
2
WED

PRICE

$1.14 ▼ DOWN 4.20% (−$0.05)
$1.14$1.15$1.17$1.189:35 AM10:39 AM11:43 AM12:47 PM1:51 PM2:55 PM3:59 PM1.14

About Telomir Pharmaceuticals, Inc. Common Stock

https://telomirpharma.com ↗

Telomir Pharmaceuticals, Inc., a pre-clinical-stage company based in Baltimore, develops TELOMIR-1, a small molecule aimed at treating age-related inflammatory conditions and aiding post-chemotherapy recovery by targeting inflammatory pathways.

INDUSTRY

Biotechnology

A PRODUCT TELOMIR PHARMACEUTICALS, INC. COMMON STOCK IS KNOWN FOR

Telomir-1
Telomir-1

Telomir-1, a pre-clinical small molecule from Telomir Pharmaceuticals, aims to treat age-related inflammatory and degenerative diseases by protecting telomeres, with potential applications in cancer, Alzheimer's, Wilson's disease, and progeria.

COMPETITORS

COMPETITOR
GERN COMPARE
LGVN COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
12
LISTED HERE
2
RANKED BY POSITION SIZE
VTS.AX
0.00% · 1.1M
IWC
0.00% · 37.7K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
3.45%
HOLDERS
45
TOP 12 OF 45 · RANKED BY POSITION SIZE
Vanguard Group Inc
1.1M sh · $1.51M
Blackrock, Inc.
291.4K sh · $405.09K
Geode Capital Management, LLC
249.1K sh · $323.95K
Millennium Management LLC
222.4K sh · $309.14K
Blackrock Inc.
87.9K sh · $422.79K
Raymond James Financial Inc
75.3K sh · $104.72K
Ubs Group AG
63.5K sh · $88.31K
State Street Corp
58.6K sh · $76.18K
Bank Of New York Mellon Corp
51.5K sh · $66.89K
Suncoast Equity Management
51.2K sh · $71.16K
Northern Trust Corp
41.8K sh · $54.4K
Xtx Topco Ltd
39.7K sh · $52.82K

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
DIRECTOR
Whalen Matthew Pratt
Purchase · 50.0K shares
2026-04-16
★
DIRECTOR
MacPherson Edward Clouston
Purchase · 50.0K shares
2026-04-16
★
DIRECTOR
Del Giudice Matthew Paul
Purchase · 50.0K shares
2026-04-16
★
OFFICER
Mushak Andriy
— · —
2026-06-03

SECTORS PEERS

PEERPRICE
IPSC$2.02COMPARE
EQ$2.39COMPARE
INMB$2.33COMPARE
KPTI$1.87COMPARE
BRNS$0.75COMPARE
GNTA$1.00COMPARE
SKYE$1.77COMPARE
MDCX$0.26COMPARE